$1.350
-0.533 (-39.46%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
PPCB-Prognose durch Analyse ähnlicher Charts
Alphio's PPCB stock price prediction model matches the current Propanc Biopharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.36 (+0.47%). The 1-week path is $1.36 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Propanc Biopharma Inc-Aktien kaufen?
Propanc Biopharma Inc (PPCB) appears to be a good buy right now due to its recent surge of 202.75% after reporting significant tumor growth inhibition of over 90% in advanced pancreatic cancer models. Additionally, the stock has shown a 25% increase over the last five days, indicating positive momentum. However, the main risk is its year-to-date change of -90.55%, suggesting high volatility and potential for further declines if the positive news does not sustain investor interest.
PPCB schloss am Friday bei $1.35, nachdem der Kurs -39.46% fallen
Propanc Biopharma Inc (PPCB) last closed at $1.35, losing -39.46%. These facts feed the 1-day and 1-week PPCB price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Propanc Biopharma Inc (PPCB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf PPCB am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für PPCB
Historically the probability of a positive August return for PPCB is 32.26%. August offers the highest probability of a positive month at 32.26%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.